Lupromax Pelumas Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Lupromax Pelumas Indonesia Tbk. trades at Rp114 (market cap 72.8B, 1.16M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 9.3× Lupromax Pelumas Indonesia Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.57M versus 1.16M). Which is the better fit depends on your goals.
| LMAX | RSCH | |
|---|---|---|
Market Cap | 72.8B | 678.4B |
Volume | 1.16M | 25.57M |
Lot | 11.62K | 255.67K |
Turnover | 135.77M | 6.57B |
Average Price | 116.8 | 256.8 |
Value | 135.77M | 6.57B |
Indicative Equilibrium Price | 114 | 258 |
Indicative Equilibrium Volume | 427 | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lupromax Pelumas Indonesia Tbk formerly PT Karya Pelumas Indonesia (the Company) was established based on Notarial Deed No. 42 dated February 27, 2017 of Meissie Pholuan, S.H., notary in Jakarta. The Company started its commercial operations in 2017.
Read more on LMAX →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →